You are using an outdated browser. Please upgrade your browser to improve your experience.

natalizumab

Ligand Summary
Description
A humanized monoclonal immunoglobulin G4 antibody to human INTEGRIN ALPHA4 that binds to the alpha4 subunit of INTEGRIN ALPHA4BETA1 and integrin alpha4beta7. It is used as an IMMUNOLOGIC FACTOR in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS and CROHN'S DISEASE.
Synonyms & Links
DrugCentral: 4970
LyCHI:  natalizumab


Target Activities